EXPERIENCE WITH DEGARELIX IN THE TREATMENT OF PROSTATE CANCER

Experience with degarelix in the treatment of prostate cancer

Degarelix is a gonadotrophin-releasing hormone (GnRH) antagonist for the first-line treatment of androgen-dependent advanced prostate cancer.It has a direct mechanism of action that blocks fp9550bk the action of GnRH on the pituitary with no initial surge in gonadotrophin or testosterone levels.Degarelix is the most extensively studied and widely a

read more

Mechanisms of pathogenicity for the emerging fungus Candida auris.

Candida auris recently emerged as an urgent public health threat, causing outbreaks of invasive infections in healthcare settings koip share price throughout the world.This fungal pathogen persists on the skin of patients and on abiotic surfaces despite antiseptic and decolonization attempts.The heightened capacity for skin colonization and environ

read more